The downward trend in IL-18 post-treatment could suggest that metformin helps to partially alleviate inflammasome-driven inflammation in PCOS, which has also been supported by other research showing metformin’s ability to modulate IL-18 levels in conditions of insulin resistance and metabolic dysfunction [19]. This evidence concerns the gene IL18 and Insulin resistance.